Abbott Laboratories (ABT) Acquisitions (2009 - 2019)

Abbott Laboratories has disclosed Acquisitions across 11 years of filings, most recently posting $82.0 million for Q2 2019.

• In Q2 2019, Acquisitions rose 355.56% year-over-year to $82.0 million; the TTM figure through Jun 2019 stood at $203.0 million (down 95.17% YoY), while the FY2017 annual figure was $17.2 billion, up 21378.75% from the prior year.
• Acquisitions came in at $82.0 million for Q2 2019 at Abbott Laboratories, up from $78.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $13.0 billion in Q1 2017 to a low of $7.0 million in Q4 2016.
• Average Acquisitions over 5 years is $2.0 billion, with a median of $78.0 million recorded in 2019.
• Year-over-year, Acquisitions soared 59271.43% in 2017 and sank 99.81% in 2018.
• Over 5 years, Acquisitions stood at $231.0 million in 2015, then tumbled by 96.97% to $7.0 million in 2016, then soared by 59271.43% to $4.2 billion in 2017, then tumbled by 99.57% to $18.0 million in 2018, then surged by 355.56% to $82.0 million in 2019.
• Per Business Quant data, the three most recent Acquisitions figures were $82.0 million in Q2 2019, $78.0 million in Q1 2019, and $18.0 million in Q2 2018.